Better to intervene early with a new valve in patients with severe aortic stenosis (AS) who are asymptomatic, even during exercise, than to wait for the disease to progress and symptoms to emerge ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window For patients ...
NEW YORK CITY -- Women with severe native aortic stenosis (AS) gained significantly better results from surgery with aortic annular enlargement (AAE) than transcatheter aortic valve replacement (TAVR) ...
ORLANDO, FL—(UPDATED) Through 5 years, TAVI with a self-expanding valve provided clinical outcomes similar to those seen with surgery in an intermediate-risk population, according to continued ...
WASHINGTON, DC—In women with symptomatic severe aortic stenosis (AS), TAVI yields better outcomes at 1 year compared with surgery, with no differences by annular size or age, according to a large ...
Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure that was once thought to be reserved for the sickest aortic stenosis patients. However, as an alternative to open heart ...
Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated with substantial decreased rates of death or stroke at one year in low-risk patients, compared ...
ATLANTA, GA — Younger, low-risk patients with aortic stenosis who need aortic valve replacement may now be able to consider a less invasive transcatheter approach rather than surgical aortic valve ...
Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic valve stenosis. With proven safety and efficacy, TAVR has become a standard therapeutic alternative to surgical ...
Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated with substantial decreased rates of death or stroke at one year in low-risk patients, compared ...
While the 30-day mortality rates were similar (0.2% for SAVR vs. 0.4% for TAVR), the 5-year survival rate was significantly better after surgery compared to TAVR (98% vs. 86%, p < 0.001). For ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results